We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Samarth Kulkarni, the Chief Executive Officer of $CRSP, sold 10,031 shares of the company on 03-21-2025 for an estimated $413,578. We received data on the trade from ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a report released on ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant ...

Harbour Investments Inc. reduced its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.9% during the 4th ...

The latest trading session saw CRISPR Therapeutics AG (CRSP) ending at $41.17 ... while the tech-heavy Nasdaq depreciated by 0.33%. The company's shares have seen a decrease of 20.9% over the ...